Tech Company Financing Transactions

Xceed Molecular Funding Round

Xceed Molecular, based in Toronto ON, received $3 million from MMV Financial.

Transaction Overview

Company Name
Announced On
1/23/2007
Transaction Type
Debt
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
50 Ronson Dr. 105
Toronto ON, M9W 1B3
Canada
Email Address
Overview
Xceed has developed the Ziplex system, a simple, yet scalable analytical platform with Flow-Thru Chip technology that will revolutionize the way scientists perform experiments.
Profile
Xceed Molecular LinkedIn Company Profile
Social Media
Xceed Molecular Company Twitter Account
Company News
Xceed Molecular News
Facebook
Xceed Molecular on Facebook
YouTube
Xceed Molecular on YouTube

Management Team

Title
Name
Email & Social
Chairman
Michael Treble
  Michael Treble LinkedIn Profile  Michael Treble Twitter Account  Michael Treble News  Michael Treble on Facebook
Chief Operating Officer
Paul Smith
  Paul Smith LinkedIn Profile  Paul Smith Twitter Account  Paul Smith News  Paul Smith on Facebook
VP - Finance
Rey Moisan
  Rey Moisan LinkedIn Profile  Rey Moisan Twitter Account  Rey Moisan News  Rey Moisan on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/23/2007: Procore Technologies venture capital transaction
Next: 1/23/2007: Teads venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary